News and Features


This week news of a new treatment for insomnia; The FDA comment on magnesium hypertension claims; Transmucosal buprenorphine linked to dental decay; Researchers assess changes in menstrual cycles in relation to COVID vaccines; And experts have their say on the best diets for 2022.

otezla 30mg single

The Food and Drug Administration (FDA) has approved Otezla (apremilast; Celgene) for the treatment of adult patients with oral ulcers associated with Behçet’s disease. The approval was based on data from the placebo controlled, double blind phase 3 RELIEF study which evaluated the efficacy and safety of apremilast in patients with Behçet’s disease and active…